retatrutide clinical effects side trial results Retatrutide Trial – My Endo Consult retatrutide peptide | peptidesskin

Anticipated retatrutide uses Obesity In the phase 2 trial of retatrutide published in the New England Journal of Medicine (NEJM), a group of 338 adults with obesity were randomly given either a placebo or one of four different doses of retatrutide: 1 mg, 4 mg, 8 mg, or 12 mg

Bohnen NI, Kotagal V, Mller MLTM, Koeppe RA, Scott PJH, Albin RL, et al

The High Protein-High Fiber Bowl contains 46g of protein and 14g of fibre from chicken, brown rice, black beans, fajita vegetables, corn and tomato salsas, and lettuce

A 1 mg starting dose would be 40 units

Clinical studies show modest reductions in triglycerides and LDL cholesterol in certain populations, but outcomes depend on baseline lipid status, medication dosage, and metabolic health markers

GLP-1, or glucagon-like peptide-1, is a hormone your body already makes throughout the day